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ABSTRACT
Listeria monocytogenes is a foodborne Gram-positive bacterial pathogen, and many of its virulence factors are either secreted
proteins or proteins covalently or noncovalently attached to the cell wall. Previous work has indicated that noncovalently at-
tached proteins with GW (glycine-tryptophan) domains are retained in the cell wall by binding to the cell wall polymer lipo-
teichoic acid (LTA). LTA is a glycerol phosphate polymer, which is modified in L. monocytogeneswith galactose and D-alanine
residues. We identified Lmo0933 as the cytoplasmic glycosyltransferase required for the LTA glycosylation process and renamed
the protein GtlA, for glycosyltransferase LTA A. Using L. monocytogenesmutants lacking galactose or D-alanine modifications or
the complete LTA polymer, we show that GW domain proteins are retained within the cell wall, indicating that other cell wall
polymers are involved in the retention of GW domain proteins. Further experiments revealed peptidoglycan as the binding re-
ceptor as a purified GW domain fusion protein can bind to L. monocytogenes cells lacking wall teichoic acid (WTA) as well as
purified peptidoglycan derived from a wild-type orWTA-negative strain. With this, we not only identify the first enzyme in-
volved in the LTA glycosylation process, but we also provide new insight into the binding mechanism of noncovalently attached
cell wall proteins.
IMPORTANCE
Over the past 20 years, a large number of bacterial genome sequences have become available. Computational approaches are
used for the genome annotation and identification of genes and encoded proteins. However, the function of many proteins is still
unknown and often cannot be predicted bioinformatically. Here, we show that the previously uncharacterized Listeria monocy-
togenes gene lmo0933 likely codes for a glycosyltransferase required for the decoration of the cell wall polymer lipoteichoic acid
(LTA) with galactose residues. Using L. monocytogenesmutants lacking LTAmodifications or the complete polymer, we show
that specific cell wall proteins, often associated with virulence, are retained within the cell wall, indicating that additional cell
wall polymers are involved in their retention.
Listeria monocytogenes is a foodborne Gram-positive bacterialpathogen and the causative agent of human listeriosis, with
immunocompromised individuals, pregnant women, and neo-
nates being at particular risk of infection (1). As part of its life
cycle, L. monocytogenes can enter phagocytic and nonphagocytic
cells. Following this, the bacterium escapes from the vacuole, rep-
licates within the host cell cytoplasm, and then spreads from cell to
cell via actin-based motility (2, 3). Numerous L. monocytogenes
proteins required for this intricate intracellular life cycle and for
the pathogenesis of this organism have been characterized over
the past decades, and many of these virulence factors are either
secreted or cell wall-associated proteins (4–6).
Proteins that are retained within the cell wall of Gram-positive
bacteria are either covalently bound to peptidoglycan through a
reaction catalyzed by sortase enzymes or retained within the cell
wall through a noncovalent interaction with peptidoglycan or
other cell wall components. Noncovalently bound proteins con-
tain specific cell wall binding domains, and in the case of L. mono-
cytogenes, these are GW (glycine-tryptophan) modules or WXL or
LysM domains (see reviews in references 6 and 7). While the func-
tion of the WXL-domain-containing proteins is unknown, most
of the proteins containing GW or LysM domains have additional
enzymatic domains predicted to contain peptidoglycan hydrolytic
activity. An exception is the GW-domain-containing protein in-
ternalin B (InlB), which aids bacteria in the entry process of hepa-
tocytic, endothelial, and epithelial cells (8–10). GW domains are
around 80 amino acids in length, and the name is derived from the
presence of a conserved glycine-tryptophan (GW) dipeptide
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within the binding domain (6, 7, 11). The GW domains are often
repeated and not present as single domains. For instance, InlB
contains three C-terminal GW domains and the autolysin Ami has
eight C-terminal GW domains (11). In previous work, a correla-
tion between the number of GW domains and the strength of
interaction with the cell wall has been observed as InlB was found
in both the cell wall and supernatant fraction, while the Ami pro-
tein, with a larger number of GW domains, was found exclusively
in the cell wall fraction (11). The cell wall polymer lipoteichoic
acid (LTA) has been implicated as the binding receptor for GW-
domain-containing proteins (12). In addition, it has also been
described that InlB binds to glycosaminoglycans present on host
cell surfaces (13, 14), indicating that sugar moieties are recognized
by the GW domains, and this was further investigated in the pres-
ent study.
The cell wall of L. monocytogenes is typical for a Gram-positive
bacterium belonging to the phylum Firmicutes. It is composed of a
thick peptidoglycan layer and teichoic acids (TAs). TAs are further
grouped into wall teichoic acid (WTA), a polymer covalently
linked to the peptidoglycan layer, and lipoteichoic acid (LTA), a
polymer anchored to the outer leaflet of the cytoplasmic mem-
brane by a glycolipid anchor (15, 16). The chemical structure of
WTA can vary between different Listeria serovars. It is either a
polyribitol-phosphate (RboP) polymer substituted withN-acetyl-
glucosamine (GlcNAc) and/or rhamnose (Rha) residues (17–19)
or a polymer made up of RboP and GlcNAc repeating units, which
can be further decorated with galactose and glucose residues (19,
20). In all cases, the WTA polymer is covalently linked via a con-
served sugar-containing linker unit to the peptidoglycan layer.
The WTA polymer itself is polymerized within the cytoplasm of
the cell on an undecaprenyl-phosphate (C55-P) lipid carrier mol-
ecule, and its synthesis is initiated by the TagO enzyme and the
production of a conserved linker unit. Two TagO enzymes with
redundant functions have been identified inL.monocytogenes, and
only depletion of both enzymes resulted in the abrogation of WTA
production in the L. monocytogenes strain EGD-e (21). Less vari-
ation is seen in the chemical structure of the LTA polymer (22, 23).
It is a polyglycerol phosphate polymer, also referred to as type I
LTA, further decorated with D-alanine and galactose residues in L.
monocytogenes strains (15, 22–24). Most enzymes required for
LTA production have now been identified; the proteins encoded
in the lafA-lafB-lafC (lafA-C) operon (LTA anchor formation) are
required for the production of the glycolipid anchor (25). The
glycerol phosphate backbone is polymerized on the outside of the
cell, and the GroP subunits are derived from the head group of
the phospholipid phosphatidylglycerol phosphate (26, 27). In L.
monocytogenes, the LTA backbone is synthesized by a two-enzyme
system, where the LTA primase LtaP initiates the production of
the glycerol phosphate backbone by the addition of the first glyc-
erol phosphate subunit to the glycolipid anchor and the LTA syn-
thase LtaS extends the chain by the repeated addition of glycerol
phosphate subunits (24, 25, 28). The proteins encoded in the dltA-
dltB-dltC-dltD (dltA-D) operon are responsible for the addition of
the D-alanine modifications on LTA (29); however, the enzymes
responsible for the modification of LTA with galactose residues
have not yet been identified.
Based on biochemical studies performed in the 1980s, a mech-
anism for the incorporation of glycosyl residues into type I LTA
has been proposed and also recently reviewed (15, 30–33) (Fig.
1A). In this model, a cytoplasmic glycosyltransferase (GT) utilizes
a nucleotide-activated sugar to form a C55-P-sugar intermediate.
Next, this intermediate is transported across the membrane by a
flippase and in a final step a second GT with extracellular activity
links the sugar onto LTA (32, 33) (Fig. 1A). The lipopolysaccha-
ride (LPS) glycosylation process in Escherichia coli with 4-amino-
4-deoxy-L-arabinose (L-Ara4N) and glycosylation processes of
complex cell wall polymers inMycobacterium tuberculosis proceed
through similar mechanisms (34–36).
Here, we identified a glycosyltransferase involved in the LTA
glycosylation process. Using L. monocytogenes mutant strains
lacking either the D-alanine or glycosyl modifications or the com-
plete LTA polymer, we show that LTA is not absolutely essential
for the retention of the GW-repeat-domain-containing cell wall
proteins InlB and Ami. We present experimental evidence that
suggests that GW domain proteins are instead retained in the cell
wall by binding to the peptidoglycan polymer. With this, we not
only identify the first enzyme involved in the glycosylation process
of type I LTA, but we also provide new insight into the binding
mechanism of noncovalently attached cell wall proteins.
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FIG 1 Model for the glycosylation process of type I LTA in L. monocytogenes and LTA production in the WT and a gtlA mutant strain. (A) Model for the
glycosylation process of type I LTA. In this model, an enzyme with a cytoplasmically located glycosyltransferase (GT) domain, likely with a GT-A fold, utilizes
UDP-Gal as the substrate to generate the C55-P-Gal lipid intermediate (step 1). Following this, the lipid-linked sugar intermediate is transferred across the
membrane, presumably with the aid of a dedicated lipid flippase (step 2), where a GT with an extracellular catalytic domain and likely assuming a GT-C fold links
the sugar onto LTA (step 3). It is of note that none of the enzymes has as of yet been identified in L. monocytogenes or any other bacterium producing type I LTA.
This figure was adapted from Percy et al. (15). (B) LTA detection by Western blotting. Extracts from strains 10403S (WT), 10403S/pPL3e (WT pPL3e), 10403S
gtlA (gtlA), 10403SgtlA/pPL3e (gtlA pPL3e), and 10403SgtlA/pPL3e-gtlA (gtlA pPL3e-gtlA) were prepared and separated in 15% PAA gels as described
in Materials and Methods. The LTA polymer was detected by Western blotting using a polyglycerol phosphate-specific monoclonal antibody; positions of protein
standards (in kilodaltons) are indicated on the left-hand side. Three independent experiments were performed, and a representative result is shown.
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MATERIALS AND METHODS
Bacterial strains and growth conditions.All strains and plasmids used in
this study are listed along with the corresponding references in Table S1 in
the supplemental material. Escherichia coli strains were grown in Luria-
Bertani (LB) medium and Listeria monocytogenes strains in brain heart
infusion (BHI) medium at 37°C unless otherwise specified. Where appro-
priate, the medium was supplemented with the following antibiotics: for
E. coli cultures, ampicillin (Amp) at 100 g/ml, kanamycin (Kan) at 30
g/ml, tetracycline (Tet) at 10 g/ml, and chloramphenicol (Cam) at
20g/ml; for L.monocytogenes cultures, chloramphenicol (Cam) at 7.5 to
10 g/ml, erythromycin (Erm) at 5 g/ml, and streptomycin (Strep) at
200 g/ml for conjugation experiments.
Strain and plasmid construction. All primers used in this study are
listed in Table S2 in the supplemental material. Allelic exchange vec-
tors pKSV7dltA, pKSV7tagO1, pKSV7tagO2, and pKSV7gtlA
(lmo0933) were constructed for the production of markerless in-frame
deletions in L. monocytogenes genes dltA, tagO1, tagO2, and gtlA, respec-
tively. For all constructs, an approximately 1-kb DNA region upstream of
the gene and the first 30 bases of the gene were fused by splicing overlap
extension (SOE) PCR (37) to the last 30 bases of the gene and an approx-
imately 1-kb DNA fragment downstream of the gene. Chromosomal
DNA isolated from L. monocytogenes strain 10403S was used as the DNA
template in all PCRs. For construction of plasmid pKSV7dltA, primer
pairs 932/933 and 934/935 were used for the first round of PCRs and
primer pair 932/935 for the second round. The PCR product was subse-
quently digested with enzymes KpnI and BamHI and ligated with vector
pKSV7, which had been cut with the same enzymes. Plasmids
pKSV7tagO1, pKSV7tagO2, and pKSV7gtlA were constructed using
a similar method but with primers 530/531/532/533 (tagO1), 537/538/
539/540 (tagO2), and 1298/1299/1300/1301 (gtlA). This created the
allelic exchange vectors pKSV7dltA, pKSV7tagO1, pKSV7tagO2,
and pKSV7gtlA, which were initially recovered inE. coli strain XL1-Blue,
yielding strains ANG1646, ANG1380, ANG1381, and ANG2222, respec-
tively. These plasmids were then introduced by electroporation into
L. monocytogenes strain 10403S, and the allelic exchange procedure
was subsequently performed as described previously (38). Strains with
the expected gene deletions were identified by PCR, and this resulted
in the construction of strains 10403S dltA (ANG1783), 10403S
tagO1 (ANG1387), 10403S tagO2 (ANG1388), and 10403S gtlA
(ANG2325). For construction of strain 10403S tagO1-2 (ANG1784)
with deletions of both tagO genes, plasmid pKSV7tagO1 was intro-
duced into strain 10403S tagO2 and the allelic exchange procedure
performed as described above. Strains 10403S tagO1-2 and 10403S
ltaS (constructed in a previous study [25]) have severe growth de-
fects, and to improve the growth of these strains they were passaged
several times at 37°C, yielding the suppressor strains 10403S tagO1-
2sup (ANG2350) and 10403S ltaSsup (ANG2337). For construction of
strain 10403S ltaP ltaSsup (ANG3465), the allelic exchange plasmid
pKSV7lmo0644 (ltaP) (25) was electroporated into L. monocyto-
genes strain 10403SltaSsup and the allelic exchange procedure performed
as described above.
Plasmids pPL3e-gtlA, pPL3-tagO1, and pHPL3-tagO2 were con-
structed for gene complementation analysis. For construction of plasmid
pPL3e-gtlA, the gtlA gene and its upstream promoter region were ampli-
fied with primer pair 1421/1422; the resulting PCR product was digested
with BamHI and KpnI and ligated with vector pPL3e, which had been cut
with the same enzymes. The resulting plasmid, pPL3e-gtlA, was recovered
in E. coli strain XL1-Blue (ANG2322) and subsequently introduced into
strain 10403S gtlA by electroporation, generating strain 10403S gtlA/
pPL3e-gtlA (ANG2495). The empty pPL3e vector was also introduced
into wild-type (WT) strain 10403S and strain 10403SgtlA, yielding con-
trol strains ANG2498 and ANG2496, respectively. For construction of
plasmids pPL3-tagO1 and pHPL3-tagO2, the tagO1 gene, including its
upstream promoter region, was amplified with primer pair 655/679 and
the tagO2 gene without the promoter region was amplified with primer
pair 657/658. The resulting PCR products were digested with enzymes
BamHI and KpnI and ligated with plasmids pPL3 and pHPL3 (containing
the constitutive hyper spac promoter), respectively. The resulting plas-
mids, pPL3-tagO1 and pHPL3-tagO2, were recovered in E. coli strain
XL1-Blue, yielding strains ANG1394 and ANG1395. Plasmids pHPL3,
pPL3-tagO1, and pHPL3-tagO2 were then introduced into the E. coli
strain SM10, yielding strains ANG1375, ANG1807, and ANG1808, re-
spectively. Plasmids pHPL3, pPL3-tagO1, and pHPL3-tagO2 were subse-
quently moved by conjugation into strain 10403S tagO1-2, yielding
strains ANG1911, ANG1832, and ANG1833, respectively.
Plasmid pHPL3-inlB-GW-His was constructed for the expression of
the C-terminally His-tagged InlB protein in L. monocytogenes under the
control of the constitutive hyper spac promoter. Plasmid pHPL3-inlB-
GWAmi-His was constructed for the expression of the C-terminally His-
tagged InlB variant in which its three native GW domains were replaced
with the eight GW domains of the Ami protein. For construction of plas-
mid pHPL3-inlB-GW-His, the inlB gene was amplified from 10403S chro-
mosomal DNA using primer pair 835/837 and the C-terminal His tag was
introduced as part of the primer sequence. The PCR product was cut with
enzymes BamHI and SalI and inserted into plasmid pHPL3, which had
been cut with the same enzymes. The resulting plasmid, pHPL3-inlB-
GW-His, was recovered in E. coli strain XL1-Blue, yielding strain
ANG1551. SOE PCR was used to create the insert inlB-GWAmi-His for the
construction of plasmid pHPL3-inlB-GWAmi-His. Specifically, the 5= inlB
fragment was amplified with primer pair 835/1172 and the sequence cod-
ing for the GW domains of the Ami protein with primer pair 1173/1119.
The PCR products were fused in a second round of PCR using primer pair
835/1119. The resulting PCR product was cut with enzymes BamHI and
SalI and inserted into plasmid pHPL3. The resulting plasmid, pHPL3-
inlB-GWAmi-His, was initially recovered in E. coli strain XL1-Blue, yield-
ing strain ANG1975. Plasmids pHPL3-inlB-GW-His and pHPL3-inlB-
GWAmi-His were either introduced into the different Listeria strains by
electroporation or first introduced into E. coli strain SM10, yielding
strains ANG1625 and ANG2014, and subsequently introduced into the
different Listeria strains by conjugation. Specifically plasmids pHPL3,
pHPL3-inlB-GW-His, and pHPL3-inlB-GWAmi-His were introduced
into the WT L. monocytogenes 10403S strain, yielding strains 10403S/
pHPL3 (ANG1414), 10403S/pHPL3-inlB-GW-His (ANG1626), and
10403S/pHPL3-inlB-GWAmi-His (ANG2015). Plasmids pHPL3-inlB-
GW-His and pHPL3-inlB-GWAmi-His were also introduced into L.
monocytogenes strains 10403S gtlA, 10403S dltA, 10403S ltaSsup,
10403S ltaP ltaSsup, and 10403S tagO1-2sup, yielding strains 10403S
gtlA/pHPL3-inlB-GW-His (ANG3330) and 10403S gtlA/pHPL3-inlB-
GWAmi-His (ANG3331), 10403S dltA/pHPL3-inlB-GW-His (ANG3333)
and 10403S dltA/pHPL3-inlB-GWAmi-His (ANG3334), 10403S
ltaSsup/pHPL3-inlB-GW-His (ANG1630) and 10403S ltaSsup/pHPL3-
inlB-GWAmi-His (ANG2037), 10403S ltaP ltaSsup/pHPL3-inlB-GW-
His (ANG3325) and 10403S ltaP ltaSsup/pHPL3-inlB-GWAmi-His
(ANG3326), and 10403S tagO1-2sup/pHPL3-inlB-GW-His (ANG2513)
and 10403StagO1-2sup/pHPL3-inlB-GWAmi-His (ANG2514), respectively.
Plasmid pVL847 is an E. coli vector used for the expression and puri-
fication of the N-terminally His-tagged maltose binding protein (His-
MBP). Plasmid pVL847-GWAmi was constructed for the expression and
purification of the His-MBP–GWAmi fusion protein, in which the eight
GW domains of the Ami protein are fused to the C terminus of the His-
MBP protein. Initially the sequence coding for the Ami GW domains was
amplified with primer pair 1320/1321, and the resulting PCR product was
cut with enzymes SacI and SalI and inserted in plasmid pQ30-GFP. The
resulting plasmid, pQE30-GFP-GWAmi, was recovered in E. coli strain
XL1-Blue, yielding strain ANG2157. Plasmid pQE30-GFP-GWAmi and
primer pair 1806/1807 were subsequently used in a PCR to amplify the
GWAmi region and the resulting product was cut with enzymes NdeI and
BamHI and ligated with plasmid pVL847, which had been cut with the
same enzymes. This generated plasmid pVL847-GWAmi, which was recov-
ered in E. coli strain in XL1-Blue, generating strain ANG3179. For protein
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expression and purification, plasmids pVL847 and pVL847-GWAmi were
introduced into E. coli strain BL21(DE3), generating strains ANG2890
and ANG3181, respectively. The DNA sequences of all inserts were con-
firmed by automated fluorescence sequencing at the MRC Clinical Sci-
ences Centre Genomics Core Laboratory, Imperial College London or at
GATC Biotech, Ltd.
LTA isolation andNMRanalysis.Cultures ofL.monocytogenes strains
10403S, 10403S gtlA, and 10403S gtlA/pPL3e-gtlA were grown over-
night at 37°C in 3 liters of BHI medium, and bacteria were pelleted by
centrifugation. The LTA was extracted and purified by hydrophobic in-
teraction chromatography using a 24- by 1.6-cm octyl Sepharose column
as previously described (26). LTA-containing fractions were identified by
Western blotting using a polyglycerol phosphate-specific antibody (26),
combined, and extensively dialyzed against double-distilled water
(ddH2O) at 4°C. The sample was then lyophilized and stored at20°C. To
analyze the LTA by one-dimensional (1D) 1H nuclear magnetic resonance
(NMR), 2 mg of purified LTA was suspended in 500 l D2O of 99.96%
purity and lyophilized. The LTA was suspended and lyophilized once
more in this way and finally suspended in 500l of D2O of 99.99% purity.
NMR spectra were acquired on a 600-MHz Bruker Avance III spectrom-
eter equipped with a TCI cryoprobe. For quantification, 1D spectra were
recorded with a 5-s recycle delay and approximately 45° proton flip angle
to ensure accurate integration. The data were analyzed in Topspin 3.1
(Bruker Biospin, Ltd.). For each strain, three independent LTA extrac-
tions were performed and analyzed by NMR, and spectra were annotated
as previously reported (39–41). To determine the chain length and degree
of backbone substitution, the area under each peak assigned to an LTA
component was integrated. The peak at 4.3 ppm derived from the nonex-
changeable proton associated with the CH group of D-Ala was used as a
reference and set to 1. Next, the total integration values for peaks belong-
ing to specific LTA components (GroP, D-Ala, Gal, or fatty acids) were
calculated. Following this, a proton adjusted value was determined for
LTA components by taking the number of nonexchangeable protons for
each component into account—that is, 58 protons for the lipid anchor, 5
for GroP, 4 for D-Ala, and 7 for Gal. To determine the chain length of LTA,
the proton-adjusted value for GroP was divided by the proton-adjusted
value for the lipid anchor. To determine the percentage of substitution,
the proton-adjusted value for D-Ala or Gal was divided by the proton-
adjusted value for GroP and multiplied by 100. The average values and
standard deviations from three independent experiments were calculated
and plotted. Statistical significance was determined using a two-tailed
unpaired Student t test.
L. monocytogenes growth curves and motility assay. Growth curves
with tagO mutant strains were undertaken as previously described (25).
Briefly, WT strain 10403S and the tagO mutant L. monocytogenes strains
were grown overnight at 30°C in 4 ml BHI medium. The next day, cultures
were diluted to a starting optical density at 600 nm (OD600) of 0.07 in 25
ml of BHI medium and incubated with shaking at 37°C, and OD600 values
were determined at timed intervals. Growth curves were performed in
duplicate, and a representative graph is shown. Growth curves with the
gtlA mutant and complementation strain were performed in 96-well for-
mat in a SPECTROStar Nano 96-well plate reader (BMG Labtech). The
indicated strains were grown overnight at 37°C in 5 ml BHI medium. The
next day, cultures were diluted in triplicate 1:50 into 200 l of fresh BHI
and incubated at 37°C with shaking for 10 h, and OD600 readings were
taken every 30 min. The background reading of wells containing BHI
medium only was subtracted from all readings and the average readings
from the triplicate samples plotted. The experiment was performed in
duplicate, and a representative result is shown. For motility assays, the
indicated L. monocytogenes strains were grown overnight in 5-ml BHI
cultures. The next day, the culture was adjusted to an OD600 of 5, 2.5 l
was used to stab inoculate low-agar (0.3% agar) BHI plates, and the plates
were subsequently incubated for 18 h at 30°C. Images were taken using a
ChemiDoc Touch imaging system (Bio-Rad). Experiments were per-
formed in triplicate, and a representative result is shown.
Cell fractionation and Western blot analysis. WT and mutant L.
monocytogenes strains were grown overnight in 5 ml BHI medium at 30°C.
Samples for the detection of cell-associated LTA were prepared and sep-
arated on 15% polyacrylamide (PAA) gels as previously described (25).
The LTA was detected by Western blotting using a polyglycerol phos-
phate-specific monoclonal LTA antibody (clone 55 from Hycult Biotech-
nology) and a horseradish peroxidase (HRP)-conjugated anti-mouse an-
tibody (Cell Signaling Technology) at 1:4,000 and 1:10,000 dilutions,
respectively. To assess the cellular localization of reporter proteins, the
different L. monocytogenes strains were grown overnight in 5 ml BHI me-
dium at 37°C (or 30°C for the 10403S tagO1-2sup/pHPL3-inlB-GW-His
[ANG2513] and 10403S tagO1-2sup/pHPL3-inlBAmi-His [ANG2514]
strains). The next day, 1.2 ml of these cultures was centrifuged at 17,000
g for 10 min to harvest the bacteria. Following this, 1 ml of the supernatant
was transferred to a fresh tube (supernatant fraction). The remaining
supernatant was aspirated, leaving a cell pellet (cell-associated fraction).
To prepare the cell-associated protein fraction, the cell pellet was sus-
pended in 2 protein sample buffer normalized for culture density; that
is, the pellet from a 1.2-ml culture with an OD600 of 2 was suspended in
120 l sample buffer. To prepare the supernatant fraction, 100 l of cold
trichloroacetic acid (TCA) was added to the 1-ml supernatant fraction,
and the sample was vortexed and incubated on ice for 1 h. Then the
samples were centrifuged at 17,000  g for 10 min, and the pellet was
washed twice with 1 ml cold acetone, followed by vortexing and incuba-
tion on ice for 1 h. The samples were centrifuged as before, the superna-
tant aspirated, and the pellet suspended in 2 protein sample buffer nor-
malized based on the OD600 readings: that is, the 1-ml supernatant
fraction derived from a culture with an OD600 of 2 was suspended in 100
l sample buffer. The supernatant and cell-associated fractions were
boiled for 20 min and centrifuged for 5 min at 17,000  g, and 10 l of
each sample was separated on a 10% polyacrylamide (PAA) gel. Proteins
were transferred to polyvinylidene difluoride (PVDF) membranes, and
Western blots were performed either using an HRP-conjugated anti-His
antibody (Sigma) at a 1:5,000 dilution, an anti-L6 ribosomal protein pri-
mary antibody at a 1:20,000 dilution, or the Ami-specific polyclonal an-
tibody R4 (11) at a 1:5,000 dilution and an HRP-conjugated anti-rabbit
secondary antibody (Cell Signaling Technology) at a 1:10,000 dilution.
For the detection of the native InlB protein, strains 10403S and EGD were
grown overnight in either BHI or BHI– 0.2% activated charcoal at 37°C
and the cell and supernatant fractions were prepared as described above.
The InlB protein was detected using the mouse monoclonal InlB antibody
R4.6 (11) at a 1:1,000 dilution and an HRP-conjugated anti-mouse sec-
ondary antibody (Cell Signaling Technology) at a 1:10,000 dilution. Blots
were developed by the enhanced chemiluminescence (ECL) method, the
signal was captured using an ECL Hyperfilm (GE Healthcare), and the
film was developed with an automated developer (AGFA-Healthcare
N.V.), or the signal was directly detected using a ChemiDoc Tough imager
(Bio-Rad).
WTA isolation anddetection by alcian blue-silver staining.The cells
from 45-ml overnight cultures of the indicated L. monocytogenes strains
were harvested by centrifugation for 10 min at 6,000 g. The pellet was
washed with 20 ml 20 mM sodium acetate (pH 4.6) buffer and suspended
in 800l of the same buffer. The cell suspension was transferred to a tube
containing an equal volume of 0.1-mm glass beads. The bacteria were
lysed in a FastPrep machine (MP Bioscience) using three 1-min runs with
2-min incubations on ice between runs. The samples were centrifuged at
200  g for 1 min to sediment the glass beads, and the supernatant was
transferred to a fresh tube. The glass beads were suspended in 750 l 20
mM sodium acetate (pH 4.6) buffer centrifuged as before, and the super-
natants were combined. The cell walls in the supernatant fractions were
harvested by centrifugation at 17,000  g for 5 min and suspended in a
final volume of 1 ml 20 mM sodium acetate buffer (pH 4.6) containing 4%
SDS. The cell wall suspensions were boiled for 30 min and transferred to a
fresh tube, and the volume was made up to 10 ml with 20 mM sodium
acetate (pH 4.6) buffer. The samples were centrifuged at 6,000 g for 10
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min and washed twice more with the same buffer. After the final centrif-
ugation step, the pellet was then suspended in 800 l of the same buffer
and centrifuged at 17,000  g for 5 min. The pellet was suspended in 20
mM sodium acetate (pH 4.6) normalized based on the OD600 reading of
the overnight culture: that is, 1 ml of a culture with an original OD600 of 1
was suspended in 10 l buffer. To liberate the WTA, NaOH was added to
a final concentration of 0.1 M and the samples were incubated at 65°C for
2 h. The sample was centrifuged for 10 min at 17,000 g, and the super-
natant was transferred to a fresh tube and stored at20°C. To analyze the
WTA, 10 l of NaOH-extracted WTA samples was mixed with 10 l of 2
M sucrose prepared in Tris-borate-EDTA (TBE) buffer, and then 5-l
aliquots were loaded onto a 15% TBE–PAA gel and run at 100 V for 1 h in
0.5 TBE buffer. The WTA was visualized using an alcian blue-silver
staining method, which was performed with minor modifications as de-
scribed previously (42). Briefly, the PAA gels were immersed in 0.5%
alcian blue solution made up in 1% acetic acid and incubated with mod-
erate shaking for 1 h at room temperature. Excess alcian blue was removed
by rinsing the gel several times with ddH2O and then incubation with
ddH2O for 1 h. Following this, the gel was fixed with 40% methanol and
10% acetic acid. Destained and fixed TBE-PAA gels were washed again in
ddH2O, and the gel was subsequently overlaid with oxidation solution
(3.4 mM potassium dichromate, 3.2 mM nitric acid) and incubated for 10
min with moderate shaking. The gels were washed twice with ddH2O and
following this immersed in 12 mM silver nitrate solution for 20 min and
then washed once briefly in ddH2O. The gel was overlaid with developing
solution (0.28 M sodium carbonate and 6 mM formaldehyde) for 10 s, and
then the solution was discarded and fresh developing solution added until
a brown precipitate was observed. To stop further coloration, the devel-
oping solution was removed and a 5% acetic acid stop solution added.
Protein expression and purification. Strains BL21(DE3)/pVL847
(ANG2890) and BL21(DE3)/pVL847-GWAmi (ANG3181) were used for
the expression and purification of the His-MBP and His-MBP-GWAmi
proteins. Protein expression was induced with 0.5 mM IPTG (isopropyl-
-D-thiogalactopyranoside) at 16°C overnight, and protein purification
by Ni-NTA and size exclusion chromatograph was essentially performed
as previously described (43), with the exception that EDTA-free protease
inhibitors (Roche) and 10 mM imidazole were added to the lysis buffer
and 20 mM Tris (pH 7.5)–200 mM NaCl–5% glycerol buffer was used for
the size exclusion chromatography step. Following size exclusion chroma-
tography, the protein-containing fractions were pooled and concentrated
using a 10-kDa-cutoff Amicon Centricon concentrator (Millipore) and
the final protein concentration was determined using the bicinchoninic
acid (BCA) assay kit (Pierce). Protein samples were snap-frozen in N2 and
then stored at80°C.
Peptidoglycan purification. Peptidoglycan was purified from the
strains 10403S and 10403S tagO1-2sup. For the WT strain, an overnight
culture was used to inoculate 1 liter of BHI medium to an OD600 of 0.06,
and the culture was grown at 37°C until it reached an OD600 of 1. For the
10403S tagO1-2sup strain, two 1-liter cultures were grown in the same
way to an OD600 of 0.5 to 0.6. From this point on, all cultures were treated
the same. Peptidoglycan was purified as previously described (44). Puri-
fied peptidoglycan sacculi were lyophilized prior to the hydrofluoric acid
(HF) treatment, their dry weight was determined, and suspensions at the
indicated concentration in milligrams per milliliter were prepared and
used in binding assays. To remove wall teichoic acid, the lyophilized pep-
tidoglycan material from strain 10403S was suspended in 48% HF at a
concentration of 2.5 mg/ml. The suspension was incubated at 4°C with
moderate agitation for 48 h. Following this, the peptidoglycans were har-
vested by centrifugation, washed twice with 25 ml ddH2O, twice with 25
ml 100 mM Tris (pH 7.5), and twice more with 25 ml ddH2O. The pepti-
doglycan was suspended in a final volume of 5 ml 100 mM (NH4)2CO3. To
this suspension, 200 U of alkaline phosphatase (Sigma) was added, and
the suspension was incubated at 37°C for 16 h on a rotator wheel. The
samples were subsequently boiled for 5 min and then washed twice with
25 ml ddH2O. The peptidoglycan was again lyophilized, the dry weight
was determined, and suspensions at the indicated concentration in milli-
grams per milliliter were prepared and used in binding assays.
Binding assays with whole cells or purified peptidoglycan and puri-
fied MBP fusion proteins. Bacteria from a 50-ml overnight culture of L.
monocytogenes strain 10403S or 10403S tagO1-2sup were harvested by
centrifugation, washed once with 20 ml 50 mM Tris (pH 8), and subse-
quently suspended in the same buffer to an OD600 of 10, 1, or 0.5. Protein
binding assays were set up in 250-l reaction and consisted of 200 l of
this cell suspension and 50 l of purified His-MBP or His-MBP-GWAmi
protein at a concentration of 40 M, giving a final protein concentration
of 8 M in the reaction mixture. Control reaction mixtures that lacked
cells (no-cell reactions) consisted of 200l 50 mM Tris (pH 8) buffer plus
50 l of protein solution. The reactions were vortexed then incubated at
room temperature for 15 min. Following this, the samples were centri-
fuged for 10 min at 17,000  g to pellet the bacteria and any bound
protein. The supernatant fraction containing the unbound protein was
moved to a fresh tube, the same volume of 2 protein sample buffer was
added, 10 l of these samples was analyzed on a 10% PAA gel, and pro-
teins were visualized by Coomassie staining. The binding assays with pu-
rified peptidoglycan were set up in a similar manner. Each 250-l reaction
mixture consisted of 200 l purified peptidoglycan suspensions (either
before or after HF treatment) at the indicated concentration in 50 mM
Tris (pH 8) buffer and 50 l of a 40 M His-MBP or His-MBP-GWAmi
protein solution. Control reaction mixtures that lacked peptidoglycan
(no-PG reactions) contained only 200l of 50 mM Tris (pH 8) buffer and
50 l of the protein solutions. The reaction mixtures were vortexed and
incubated at room temperature on a rotator wheel for 15 min and subse-
quently prepared and analyzed as described above for whole-cell binding
assays.
Whole-genome sequencing and bioinformatics analysis. Genome se-
quencing ofL.monocytogenes strains 10403S, 10403SltaSsup (ANG2337),
and 10403S tagO1-2sup (ANG2350) was performed by microbesNG
(http://microbesng.uk) using an Illumina MiSeq platform and 2 250-bp
paired-end reads. The CLC genomics workbench software package (Qia-
gen) was used to map the reads to the 10403S reference genome sequence
(RefSeq accession no. NC_017544.1), and high-confidence and high-fre-
quency (85%) changes are listed in Table S3 for the different strains. To
determine the conservation of the gtlA gene among other Listeria species,
a synteny analysis was performed using the SyntTax web server (http:
//archaea.u-psud.fr/synttax/) and all available sequenced Listeria ge-
nomes (45)
Nucleotide sequence accession number. The genome sequence data
have been deposited in the European Nucleotide Archive under accession
no. PRJEB11525 (http://www.ebi.ac.uk/ena/data/view/PRJEB11525).
RESULTS
Identification of a type I LTA glycosyltransferase in L. monocy-
togenes. Glycosyltransferases (GTs) belonging to the GT2 family
of glycosyltransferase enzymes have been shown to catalyze, in the
presence of divalent cations, the transfer of sugar moieties from a
nucleotide-activated precursor onto the lipid carrier molecule
C55-P. Therefore, we hypothesized that the cytoplasmic GT in-
volved in the glycosylation process of type I LTA is a GT2 family
member (Fig. 1A). To identify such enzymes in L. monocytogenes,
a BLAST search was performed using the E. coli ArnC protein,
which transfers 4-amino-4-deoxyl-4-formamido-L-arabinose (L-
Ara4FN) from UDP--L-Ara4FN onto C55-P (34), as the query
sequence. Two proteins, Lmo0933 and Lmo2550, with E values of
1e35 and 1e42, respectively, were identified as the closest
ArnC homologues in the L. monocytogenes EGD-e genome, corre-
sponding to proteins LMRG_02032 and LMRG_01697 in L.
monocytogenes strain 10403S, which was used in this study. Re-
cently, it has been shown that Lmo2550 is required for the modi-
fication of WTA with GlcNAc residues (46), and therefore our
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further analysis focused on Lmo0933. An in-frame deletion was
generated in lmo0933, which as discussed below was renamed gtlA,
yielding strain 10403S gtlA. In addition a complementation
strain, 10403S gtlA/pPL3e-gtlA, was constructed, in which gtlA
was expressed from its native promoter in the chromosomal inte-
gration vector pPL3e. As additional controls, the empty pPL3e
vector was also introduced into the WT and the gtlA mutant
strains. To assess if deletion of gtlA affects LTA production, we
initially performed a Western blot analysis on cell extracts pre-
pared from the different strains using a polyglycerol phosphate-
specific monoclonal LTA antibody. As shown in Fig. 1B, a polyg-
lycerol phosphate polymer was produced by all strains. However,
the signal obtained from the extract prepared from the gtlA mu-
tant strain was noticeably stronger than that obtained from ex-
tracts prepared from the WT strain, indicating structural changes
in the LTA polymer. This phenotype could be complemented by
the introduction of the vector pPL3e-gtlA but not the empty vec-
tor (Fig. 1B). To determine the exact nature of these structural
changes, LTA was purified from the wild-type (WT) L. monocyto-
genes strain 10403S, as well as the gtlA (gtlA) mutant and the
complementation strain 10403SgtlA/pPL3e-gtlA (gtlAcompl). La-
bile protons were exchanged with deuterons by repeated suspen-
sion and freeze-drying of the LTA samples in D2O, and the sam-
ples were subsequently analyzed by 1D 1H NMR (Fig. 2). The LTA
isolated from the WT strain yielded the expected NMR spectrum,
and peaks obtained from the nonexchangeable protons could be
assigned to the different LTA components using previously pub-
lished spectra as references (39–41). Specifically, peaks derived
from the CH2 and CH3 groups within the fatty acids (highlighted
in orange), the CH2 groups from the glycerol backbone (high-
lighted in green), the CH3 and CH groups from the D-Ala modi-
fication (highlighted in blue), and CH and CH2 groups from the
galactose substitutions (highlighted in yellow) could be assigned
as indicated in Fig. 2. The galactose-specific peaks were absent in
the NMR spectrum from the LTA sample obtained from strain
10403S gtlA. The NMR spectrum for the LTA derived from
strain 10403S gtlA/pPL3e-gtlA (gtlAcompl) was nearly identical to
that obtained from the WT strain, showing that this defect was
complemented by the reintroduction of gtlA (Fig. 2). These data
suggest that Lmo0933 is likely the cytoplasmic glycosyltransferase
required for the glycosylation of type I LTA, and hence Lmo0933
was renamed GtlA, for glycosyltransferase LTA A.
LTA glycosylation does not affect LTA chain length or D-ala-
nylation. To assess if the absence of the galactosyl modifications
affects the chain length of LTA and/or the amount of D-alanine
modification, the peaks in the NMR spectra were integrated and
the chain length and percentage of alanine and galactose substitu-
tions were calculated as described in Materials and Methods. The
NMR spectra from three independently isolated LTA samples
were analyzed for each strain and the average values and standard
deviations plotted (Fig. 3). The LTA isolated from the WT 10403S
strain had an average chain length of 15.6  4.5 GroP repeating
FIG 2 Chemical structure and NMR analysis of LTA isolated from WT L. monocytogenes strain 10403S, the gtlA (lmo0933) mutant, and the complementation
strain. (A) Chemical structure of type I LTA synthesized by L. monocytogenes. Colored boxes indicate nonexchangeable protons in the LTA, which are referred
to in the text and shaded in the same colors in the NMR spectra. Peaks highlighted in gray are derived from residual citrate, a buffer component used during the
LTA purification process. (B to D) NMR spectra of LTA samples derived from L. monocytogenes strains (B) 10403S (WT), (C) 10403S gtlA (gtlA), and (D)
10403SgtlA/pPL3e-gtlA (gtlAcompl). The signals derived from the nonexchangeable protons were assigned to the different LTA components based on previously
published spectra (39–41). The spectra are representative of at least three independent experiments.
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units modified with 59.9% 2.7% D-Ala and 23.8% 4.3% Gal
substitutions, respectively. No statistically significant difference in
the LTA chain lengths and percentages of D-alanine substitution
was detected for the LTA isolated from strain 10403S gtlA and
the complementation strain compared to the sample derived from
the WT strain (Fig. 3). Furthermore, the amount of galactosyl
substitutions could be restored to wild-type levels in the comple-
mentation strain (Fig. 3). These data indicate that the absence of
galactosyl residues affects neither the LTA chain length nor the
amount of D-alanylation.
Phenotypic characterization of a gtlA mutant strain. A phe-
notypic analysis of the 10403SgtlA strain revealed that the galac-
tosyl modification on LTA is not required for growth in broth
culture or flagellum-based motility (Fig. 4). In previous work, it
has been shown that an L. monocytogenes strain lacking D-Ala
modifications on LTA is more sensitive toward cationic antimi-
crobial peptides and the antibiotic nisin (29). To test if the absence
of galactose modifications on LTA similarly affects the antibiotic
susceptibility of strain 10403S gtlA, the MIC toward nicin was
tested. No difference was observed, and the WT and mutant
strains had identical MICs of 12.5 g/ml. These data indicate that
in contrast to the D-alanine modifications on LTA, galactose mod-
ifications do not play a role in cationic antimicrobial resistance.
Identical MIC values for the cell wall-targeting antibiotics ampi-
cillin and penicillin G of 0.125 g/ml and 3.125 g/ml, respec-
tively, were also observed for the WT and gtlA mutant strains,
suggesting that the mutant strain does not have any major defects
in its peptidoglycan structure.
GW-domain-containingproteins are retained in the cellwall
of L. monocytogenesmutants lacking LTAmodifications. While
an L. monocytogenes strain lacking glycosyl modification on LTA
did not show any obvious growth phenotypes, previous work has
indicated that LTA serves as binding receptor for the GW-do-
main-containing cell wall proteins InlB and Ami (12). Therefore,
we next wanted to test if this modification is required for the
retention of noncovalently attached cell wall proteins. The en-
zymes required for the synthesis of the LTA backbone (25), D-Ala
substitutions (29), and Gal substitutions have now been identi-
fied, and this allowed us to address this question using the differ-
ent mutant strains. In previous work, it has been shown that dur-
ing exponential growth, a large amount of the InlB protein is
retained in strain EGD in a GW-domain-dependent manner
within the cell wall fraction, with some of the protein released into
the supernatant fraction (11). Using a similar fractionation exper-
iment and an InlB-specific antibody, we found that after overnight
growth, the InlB protein is exclusively found in the cell wall frac-
tion of strain EGD (Fig. 5A). Here it is of note that it was recently
found that strain EGD contains a pfrA* allele leading to increased
production of many virulence factors (47). As the different LTA
mutant strains have been constructed in the 10403S strain back-
ground, we next attempted to assess the InlB localization in strain
10403S. However, even following growth in BHI– 0.2% activated
charcoal medium, which is known to induce the expression of
PrfA-dependent virulence proteins such as InlB, we were unable
to detect significant amounts of the native InlB protein in strain
10403 (Fig. 5A). Hence we could not assess the localization of the
InlB protein when expressed from the native promoter in strain
10403S. Therefore, we next constructed plasmids pHPL3-inlB-
GW-His and pHPL3-inlB-GWAmi-His for the expression of C-ter-
minally His-tagged InlB (referred to as InlB-GW-His) as well as a
FIG 3 Determination of the LTA chain length and percentages of D-Ala and Gal substitutions. LTA was extracted from strains 10403S (WT) and 10403S gtlA
(gtlA) and the complementation strain 10403S gtlA/pPL3e-gtlA (gtlAcompl) and analyzed by NMR as shown in Fig. 2. The peaks were integrated and (A) the
chain length and (B) the percentages of D-Ala and Gal substitutions were determined as described in Materials and Methods. The average values and standard
deviations from three independent experiments are plotted. Statistical significance was determined using a two-tailed unpaired Student t test, and only a
statistical difference with aP value of	0.05 was observed for the percentage of Gal substitution between the gtlAmutant and the WT or complementation strains.
Otherwise the lowest P value was P
 0.2, indicating that there is no statistical significance difference in LTA chain length and percentage of D-Ala modifications
between all three strains or the percentage of Gal substitution between the WT and the complementation strain.
FIG 4 Growth and motility of the L. monocytogenes strain WT, gtlA mutant,
and complementation strain. (A) Bacterial growth curve. L. monocytogenes
strains 10403S (WT) and 10403S gtlA (gtlA) and the complementation
strain 10403S gtlA/pPL3e-gtlA (gtlAcompl) were grown in BHI medium in
96-well plates at 37°C, and OD600 readings were determined at the indicated
time points and plotted. (B) Plate motility assay. The same L. monocytogenes
strains as in panel A were stab inoculated on low-agar (0.3%) BHI plates and
incubated at 30°C for 18 h. The experiment was performed in triplicate, and a
representative result is shown.
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variant of InlB in which its three native GW domains were re-
placed with the eight GW domains of the Ami protein (referred to
as InlB-GWAmi-His) from the strong and constitutive hyper spac
promoter. These single-site integration vectors were initially in-
troduced into the WT L. monocytogenes strain 10403S and strains
10403S gtlA and 10403S dltA, lacking Gal and D-Ala modifica-
tions on their LTA, respectively. The empty vector pHPL3 was also
integrated into the chromosome of strain 10403S, to yield a neg-
ative-control strain. All strains were grown overnight in liquid
culture, a cell fractionation experiment was performed, and the
His-tagged proteins were subsequently detected by Western blot-
ting in the pellet (cell wall-associated proteins) and supernatant
fraction. As expected, no band was detected in samples prepared
from the 10403S control strain containing the empty vector (Fig.
5B and C). Clear bands for the InlB-GW-His and InlB-GWAmi-
His reporter proteins could be detected in all other samples. More
importantly, the reporter proteins were detected in the cell pellet
fraction for all strains, and no signal was detected in the superna-
tant fractions, indicating that neither the D-alanine nor the Gal
modification on LTA is required for the retention of GW-domain-
containing proteins within the cell wall of L. monocytogenes (Fig.
5B and C).
GWdomain proteins are retained in the cell wall of L.mono-
cytogenes mutants lacking the LTA polymer. Next, we investi-
gated whether or not the GW domain proteins would bind
directly to the polyglycerol phosphate backbone of LTA. Strain
10403S ltaS, which produces the GroP-glycolipid intermedi-
ate but is unable to polymerize the LTA backbone chain, was
constructed in a previous study (25). This strain has a severe
growth defect at 37°C, and bacteria tend to lyse (25). This makes
this strain difficult to handle and transform with plasmids, so a
suppressor strain, 10403S ltaSsup, with improved growth was
generated by repeated passage at 37°C. The 10403S strain used in
this study has four high-frequency and high-quality single nucle-
otide polymorphisms (SNPs), compared to the genome sequence
of strain 10403S deposited under RefSeq accession no.
NC_017544.1 (see Table S3 in the supplemental material). Whole-
genome sequencing revealed that strain 10403S ltaSsup has eight
additional SNPs compared to our WT strain. Two of these SNPs
are in intergenic regions, and six are within coding regions, and of
these two are within genes coding for enzymes that are directly
related to cell wall synthesis, namely the peptidoglycan hydrolase
Iap (or p60) and the D-glutamyl-L-m-Dpm peptidase P45. The
nucleotide substitution in iap does not lead to an actual amino
acid substitution, and it is therefore unclear if this SNP affects the
protein function (see Table S3 in the supplemental material). On
the other hand, the single nucleotide insertion in the P45 gene
leads to a frameshift mutation and likely inactivation of the en-
zyme, potentially causing changes in the peptidoglycan structure.
In addition to these SNPs, strain 10403S ltaSsup has the engi-
neered large deletion in the ltaS gene and was therefore still unable
to produce the LTA polymer, as assessed by Western blot analysis
(Fig. 6A). Of note, strain 10403S ltaSsup was still able to produce
the other cell wall polymer, WTA (Fig. 6B). In order to also pre-
vent the synthesis of the GroP-glycolipid intermediate, the ltaP
gene was then deleted, yielding the double mutant 10403S ltaP
ltaSsup strain, which was, as expected, LTA negative and WTA
positive (Fig. 6A and B). Next, plasmids pHPL3-inlB-GW-His and
pHPL3-inlB-GWAmi-His were introduced into strains 10403S
ltaSsup and 10403SltaPltaSsup, and the cellular location of the
reporter proteins was assessed by a cell fractionation and Western
blot experiment. Surprisingly, the signal for the reporter protein
was again detected in the pellet fraction in both strains, revealing
that GW-domain-containing proteins can be retained within the
cell wall, even in a strain completely lacking the LTA polymer (Fig.
6C and D). To investigate this further, we also assessed the local-
ization of the Ami protein in wild-type as well as mutant L. mono-
cytogenes strains lacking LTA or its modification. As observed for
the InlB constructs, the native Ami protein was primarily found
within the cell wall fraction but was absent from the supernatant
fraction (Fig. 6E). Taken together, these data suggest that the LTA
polymer is not the only cell wall receptor for GW-domain-con-
taining proteins in L. monocytogenes.
Assessing the contribution of WTA in the retention of GW-
domain-containing cell wall proteins. The two other major cell
wall polymers in L. monocytogenes are WTA and peptidoglycan.
WTA synthesis is initiated in the cytoplasm of the cell by a reaction
catalyzed by the TagO enzyme. L. monocytogenes contains two
tagO genes, lmo0959 (or LMRG_02058 in strain 10403S and re-
ferred to as tagO1) and lmo2519 (or LMRG_01729 in strain
10403S and referred to as tagO2). A WTA depletion strain has
been described recently in the EGD-e strain background, in which
FIG 5 Western blot analysis for the detection of InlB or His-tagged GW do-
main reporter proteins in the cell or supernatant fraction of L. monocytogenes
strains lacking LTA modifications. (A) Cell and supernatant samples were
prepared from overnight cultures of L. monocytogenes strains 10403S and EGD
grown in BHI or BHI– 0.2% activated charcoal (BHI  0.2% AC) medium,
and the InlB protein was detected by Western blotting. Ten microliters of the
cell-associated protein samples (Cell) or supernatant samples (Sup) was sepa-
rated on 10% PAA gels, and the InlB protein was detected using an InlB-
specific antibody at a 1:1,000 dilution and an HRP-conjugated anti-mouse
antibody at a 1:10,000 dilution, respectively. (B and C) Cell and supernatant
samples were prepared from overnight cultures of L. monocytogenes strains
10403S (WT), 10403SgtlA (gtlA), and 10403SdltA (dltA) containing (B)
plasmid pHPL3-inlB-GW-His (InlB-GW-His) or (C) plasmid pHPL3-inlB-
amiGW-His (InlB-GWAmi-His) and subsequently analyzed by Western blot-
ting as described in panel A using an HRP-conjugated anti-His antibody at a
1:1,000. The positions of the protein molecular mass markers are indicated on
the left in kilodaltons. Representative blots from three independent experi-
ments are shown.
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both tagO genes were deleted and the tagO1 gene was expressed in
trans from an IPTG-inducible promoter (21). The strain showed a
severe growth defect. In order to assess the contribution of WTA
in the retention of GW-domain-containing proteins, we consec-
utively deleted both tagO genes in the 10403S strain background,
yielding strain 10403S tagO1-2. As expected, the double tagO
mutant strain 10403StagO1-2 lacked WTA (Fig. 7A) but was still
able to produce the LTA polymer (Fig. 6A). This strain exhibited a
severe growth defect, and both WTA production and the growth
defect could be complemented by expression of either of the tagO
genes (Fig. 7B). Next, we set out to assess the contribution of WTA
in the cell wall retention of GW-domain-containing proteins.
However, strain 10403S tagO1-2 was very difficult to grow and
the bacteria were prone to lyse, so we were not able to introduce
plasmids pHPL3-inlB-GW-His and pHPL3-inlB-GWAmi-His for
expression of the reporter proteins into this strain. Only after
strain 10403S tagO1-2 was passaged several times in broth cul-
ture and the suppressor strain 10403StagO1-2sup with improved
growth was obtained was it possible to introduce plasmids
pHPL3-inlB-GW-His and pHPL3-inlB-GWAmi-His. As deter-
mined by whole-genome sequencing, strain 10403S tagO1-2sup
contained, besides the engineered deletions in the tagO genes, a
single SNP. This SNP is in plsX coding for an acyl-acyl carrier
protein (ACP) phosphate acyltransferase, which is involved in
membrane lipid biosynthesis (48). Strain 10403S tagO1-2sup
was, as expected, unable to produce WTA but was still able to
produce LTA (Fig. 6A and B). 10403StagO1-2sup-derived strains
were, however, still very fragile, as exemplified by the following
observation: boiling wild-type 10403S bacteria in protein sample
buffer does not lead to cell lysis and release of cytoplasmic pro-
teins, such as the ribosomal protein L6 (Fig. 7C and D), yet the
same treatment leads to cell lysis and release of cytoplasmic pro-
teins in strain 10403S tagO1-2sup (Fig. 7C and D). With this
caveat in mind, we still went ahead and performed a cell fraction-
ation experiment aimed to detect the InlB-GW-His and InlB-
GWAmi-His proteins in the cell pellet or supernatant fraction.
Only very small amounts of full-length proteins could be detected,
and these were detected predominately in the supernatant fraction
(Fig. 7C and D). These results indicate that GW domain proteins
might be retained in the cell wall by binding to the WTA structure.
However, given the severe growth defect and fragile nature of the
WTA-negative strain, these data need to be interpreted with cau-
tion. As described below, we therefore set up an alternative
method to assess the contribution of WTA as the binding receptor
for GW-domain-containing proteins.
The purified MBP-GWAmi fusion protein can bind to L.
monocytogenes cells lacking WTA. Purified proteins containing
GW domains can bind to WT L. monocytogenes cells when added
externally (11). We now wanted to test if such reporter proteins
could also bind to L. monocytogenes cells lacking WTA. To this
end, an E. coli plasmid for the expression of an N-terminally His-
tagged maltose binding protein (His-MBP) fused to the Ami GW
domains was constructed. The His-MBP-GWAmi fusion protein as
well as the His-MBP control protein were expressed in E. coli and
FIG 6 LTA, WTA, and Western blot analysis for the detection of His-tagged GW domain reporter proteins and Ami protein in the cell or supernatant fraction
ofL.monocytogenes strains lacking the LTA polymer. (A) Detection of LTA by Western blotting. Extracts from strains 10403S (WT), 10403SltaS (ltaS), 10403S
ltaAsup (ltaSsup), 10403S ltaP ltaSsup (ltaPltaSsup), and 10403S tagO1-2sup (tagO1-2sup) were prepared and separated on 15% polyacrylamide gels as
described in Materials and Methods. The LTA polymer was detected by Western blotting using a polyglycerol phosphate-specific monoclonal antibody; positions
of protein standards (in kilodaltons) are indicated on the left-hand side. (B) Detection of WTA by alcian blue and silver staining. WTA was isolated from the same
L. monocytogenes strains as in panel A, separated on a native polyacrylamide gel, and WTA visualized as described in Materials and Methods by an alcian
blue-silver staining procedure. (C and D) Cell and supernatant samples were prepared from overnight cultures of L. monocytogenes strains 10403S (WT), 10403S
ltaSsup, and 10403S ltaP ltaSsup containing (C) plasmid pHPL3-inlB-His (InlB-GW-His) or (D) plasmid pHPL3-inlB-amiGW-His (InlB-GWAmi-His), and
His-tagged proteins were detected by Western blot analysis as in Fig. 4. (E) Western blot analysis for the detection of Ami in the cell or supernatant fraction of
L. monocytogenes strains lacking LTA or its modifications. Cell and supernatant samples were prepared from overnight cultures of L. monocytogenes strains
10403S (WT), 10403S gtlA (gtlA), 10403S dltA (dltA) and 10403S ltaSsup (ltaSsup.). Ten microliters of the cell-associated protein samples (Cell) or
supernatant samples (Sup) was separated on 10% PAA gels, and the Ami protein was detected using a polyclonal rabbit antibody at 1:5,000. The positions of the
protein molecular mass markers are indicated on the left in kilodaltons. Representative results from three independent experiments are shown.
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purified by Ni-affinity and size exclusion chromatography. Of
note, a similar construct for expression of the His-MBP-GWInlB
fusion protein was made; however, the protein aggregated during
the purification process and could not be used for further analysis.
Next, the purified His-MBP and His-MBP-GWAmi fusion pro-
teins were incubated with cell suspensions derived from strain
10403S (WT) or the WTA-deficient strain 10403S tagO1-2sup
(WTA negative). Suspensions of different densities corresponding
to OD600 readings of 10, 1, or 0.5 were used, and as a control, the
purified proteins were also incubated in the absence of cells (“no-
cell” samples). The samples were then centrifuged to pellet the
bacteria and any bound protein, and then the supernatant fraction
was removed and analyzed by SDS-PAGE, and any unbound pro-
tein was visualized by Coomassie staining. As expected, the His-
MBP control protein did not bind to the bacterial cells and the
protein was recovered in the supernatant fraction in all samples,
regardless of whether the protein was incubated in the absence of
cells or in the presence of WT or 10403StagO1-2sup cells (Fig. 8).
Also as expected, the His-MBP-GWAmi bound and pelleted with
WT bacteria and was completely removed from the supernatant
fraction when using high-density cell suspension and partially re-
moved when using lower cell density suspensions (Fig. 8A). A
similar result was obtained when 10403StagO1-2sup cell suspen-
sions were used, as the reporter protein pelleted with the bacteria
and was absent from the supernatant fraction when high-density
cell suspensions were used or was only partially recovered in the
supernatant fraction when lower-density cell suspensions were
used (Fig. 8B). These results suggest that WTA is not required for
the cell wall binding of GW domain proteins.
The purified MBP-GWAmi fusion protein binds to purified
peptidoglycan. To investigate whether GW-domain-containing
proteins might directly bind to peptidoglycan, this cell wall poly-
mer was purified from the WT strain 10430S as well as the
WTA-deficient strain 10403S tagO1-2sup. Part of the pepti-
doglycan purification process involves treatment of the sample
with concentrated hydrofluoric acid (HF) to remove WTA. How-
ever, as the peptidoglycan was also purified from a WTA-deficient
strain, binding assays were initially performed with peptidoglycan
samples prior to HF treatment. The recombinant His-MBP and
His-MBP-GWAmi proteins were incubated in the absence of pep-
tidoglycan (no PG) or in the presence of peptidoglycan isolated
from either the WT or WTA-deficient strains and used at concen-
trations of 2.5, 0.5, or 0.25 mg/ml. Similar to whole cells, the pu-
rified peptidoglycan material plus any bound protein was re-
moved by centrifugation. As expected, the His-MBP control
protein was recovered in all samples in the supernatant fraction,
FIG 7 Growth, WTA detection, and Western blot analysis for the detection of His-tagged GW domain reporter proteins in the cell or supernatant fraction of L.
monocytogenes strains lacking the WTA polymer. (A) Detection of WTA by alcian blue and silver staining. WTA was isolated from the indicated L. monocytogenes
strains, separated on a native polyacrylamide gel, and WTA visualized as described in Materials and Methods by an alcian blue-silver staining procedure. (B)
Bacterial growth curve. Overnight cultures of the WT L. monocytogenes strain 10403S, the single tagO1 and tagO2 mutants, and the double tagO1 tagO2 mutant
as well as the tagO1-2 double mutant strain containing the complementation vector pPL3-tagO1 or pHPL3-tagO2 were diluted to a starting OD600 of 0.07, and
cultures were incubated at 37°C. Bacterial growth was monitored by determining OD600 readings at the indicated time points. Representative graphs of two
independent experiments are shown. (C and D) Cell and supernatant (Sup) samples were prepared from overnight cultures of L. monocytogenes strains 10403S
(WT) and 10403S tagO1-2sup containing (C) plasmid pHPL3-inlB-His (pHPL3-InlB-His) or (D) plasmid pHPL3-inlB-GWAmi-His. Strain 10403S (WT)
containing the empty vector pHPL3 was used as the negative control. For the top panel, His-tagged proteins were detected as described in Fig. 5 using an
HRP-conjugated anti-His antibody, and in the bottom panel, membranes were incubated with an anti-L6 ribosomal protein primary antibody and an HRP-
conjugated antirabbit secondary antibody. The positions of protein molecular mass markers are indicated on the left of each panel in kilodaltons. Representative
blots from three independent experiments are shown.
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showing that the MBP does not bind nonspecifically to purified
peptidoglycan (Fig. 9). On the other hand, the His-MBP-GWAmi
fusion protein bound to the peptidoglycan purified from the WT
strain and was therefore no longer found in the supernatant frac-
tion at the highest peptidoglycan concentration or found at re-
duced levels in the supernatant fraction at the lower peptidoglycan
concentrations (Fig. 9A). The His-MBP-GWAmi protein showed
even better binding to the peptidoglycan sample isolated from a
WTA-deficient L.monocytogenes strain, and no protein was recov-
ered in the supernatant fraction, even at a peptidoglycan concen-
tration of 0.5 mg/ml (Fig. 9B). It has been estimated that WTA
constitutes up to 70% of the cell wall dry weight in Listeria (20):
hence the increased binding of the His-MBP-GWAmi to the pep-
tidoglycan isolated from the WTA-negative strain compared to
the peptidoglycan isolated from a WT strain might be due to the
fact that the samples were normalized based on dry weight. Lastly,
the peptidoglycan isolated from the WT L. monocytogenes strain
treated with concentrated HF to chemically remove WTA was also
FIG 8 Binding of purified His-MBP-GWAmi to whole cells of wild-type and WTA-deficient L. monocytogenes cells. Purified His-MBP or His-MBP-GWAmi
protein was incubated in the absence of cells or in the presence of (A) 10403S (WT) cell suspensions or (B) 10403StagO1-2sup (WTA-negative) cell suspensions.
“No cells” indicates control samples where the proteins were incubated without cells, and samples where the protein was incubated with bacterial suspensions are
labeled “OD600
 10,” “OD600
 1,” or “OD600
 0.5,” depending on cell densities. Cells and bound protein were removed by centrifugation, and then an aliquot
of the supernatant fraction was analyzed by SDS-PAGE and proteins visualized by Coomassie staining. The His-MBP and His-MBP-GWAmi proteins have
predicted sizes of 45 kDa and 118 kDa, respectively. The positions of protein molecular mass markers are indicated on the left in kilodaltons. Representative gels
from three independent experiments are shown.
FIG9 Binding of His-MBP-GWAmi to purified peptidoglycan isolated from wild-type or WTA-deficient L.monocytogenes cells. (A and B) Peptidoglycan isolated
from strain 10403S (WT) or the WTA-deficient strain 10403StagO1-2sup (WTA negative) was suspended at the indicated concentration prior to HF treatment
and incubated with purified His-MBP or His-MBP-GWAmi protein. “No PG” indicates control samples where the proteins were incubated without peptidogly-
can. Peptidoglycan and bound protein were removed by centrifugation, an aliquot of the supernatant fraction was analyzed by SDS-PAGE, and the proteins were
visualized by Coomassie staining. (C) Peptidoglycan isolated from strain 10403S (WT) was suspended at the indicated concentration after HF treatment to
chemically remove WTA and incubated with purified His-MBP or His-MBP-GWAmi protein and processed as described above. The His-MBP or His-MBP-
GWAmi proteins have predicted sizes of 45 kDa and 118 kDa, respectively. The positions of protein molecular mass markers are indicated on the left in kilodaltons.
Representative gels from three independent experiments are shown.
Cell Wall Binding of GW Domain Proteins
August 2016 Volume 198 Number 15 jb.asm.org 2039Journal of Bacteriology
 o
n
 July 22, 2016 by Im
perial College London
http://jb.asm.org/
D
ow
nloaded from
 
used in binding assays. The His-MBP-GWAmi protein also bound
to this peptidoglycan sample (Fig. 9C), altogether suggesting that
the peptidoglycan polymer is sufficient for the retention of GW-
domain-containing proteins within the cell wall of L. monocyto-
genes.
DISCUSSION
Very little is known about the mechanism by which type I LTA is
glycosylated, and to the best of our knowledge, we have identified
in the present study the first genetic determinant required for this
process, namely, the L. monocytogenes gene lmo0933 (renamed
gtlA for glycosyltransferase LTA A) (Fig. 2 and 3). The biological
function of the sugar modifications on LTA is currently not
known, and no difference in growth rates was observed between a
WT L. monocytogenes strain and the gtlA mutant under standard
laboratory growth conditions (Fig. 4). Based on a comprehensive
transcriptomics study on the L. monocytogenes strain EGD-e by
Toledo-Arana et al. (49), gtlA is predicted to be the first gene of a
two-gene operon formed together with lmo0932 (lmrg_02031)
coding for a membrane protein of unknown function and pre-
dicted to contain a SNARE membrane fusion domain. In the same
study, no change in gtlA expression was observed during the sta-
tionary phase, hypoxia, or at low temperature or during growth in
a mouse model of infection compared to growth at 37°C in BHI
medium. Only when bacteria were grown in human blood, was a
2-fold decrease in expression observed (49). This indicates that
gtlA may not be part of the general stress response pathway in L.
monocytogenes. A BLAST and synteny analysis suggests that GtlA is
present in a number of the other sequenced L. monocytogenes
strains (13 strains out of 22 analyzed), as well as inListeria ivanovii,
and Listeria seeligeri; however, it is absent in Listeria grayi, Listeria
innocua, or Listeria welshimeri (see Table S4 in the supplemental
material). This indicates that in the latter strains, LTA is either not
glycosylated or is modified with a different sugar or that an en-
zyme at a different chromosomal location performs this function.
To investigate a potential biological function of the glycosyl
modification on LTA, we assessed its contribution in the retention
of noncovalently attached GW-domain-containing proteins
within the cell wall of L. monocytogenes. The identification of the
genetic determinants required for LTA production and its modi-
fications allowed us to construct L. monocytogenes strains lacking
D-alanine or galactose modifications or the complete LTA poly-
mer. Using these strains, we could subsequently assess the contri-
bution of LTA and its modification in the retention of GW-do-
main-containing proteins in living cells. Somewhat surprisingly,
our analysis revealed that neither the modifications on LTA nor
the actual LTA polymer was absolutely required for the cell wall
retention of the GW-domain-containing proteins (Fig. 5 and 6).
Through further work using a WTA-negative strain, as well as
purified peptidoglycan, we identified the peptidoglycan polymer
as a second binding receptor for GW domain proteins (Fig. 8 and
9). This situation is reminiscent of the binding mode of the major
autolysin Atl to the cell wall of Staphylococcus aureus. Atl is a bi-
functional enzyme with both amidase and glucosaminidase do-
mains, which are fused to the cell wall binding repeat domains.
After multiple processing steps, the amidase domain remains
linked to the repeat domains R1a/R1b and R2a/R2b and the glu-
cosaminidase domain is preceded by the repeat domains R3a/R3b.
These repeat domains share similarity to the GW domains found
in L. monocytogenes proteins and are also, in the case of the Atl
protein, essential for binding to the cell wall of S. aureus (50). The
repeat domains in Atl also contain the highly conserved glycine-
tryptophan (GW) motif, and based on their structural similarity
to the eukaryotic Src homology 3 (SH3) domains, they have been
grouped along with the GW domains found in L. monocytogenes
proteins as SH3b (bacterial SH3) domains (14, 51, 52). Initial
experiments indicated a direct interaction between the Atl repeat
domains and the peptidoglycan polymer in S. aureus (53), and
subsequent studies identified an additional interaction between
the repeat domains and the LTA polymer (51, 52). Based on the
findings presented in these previous studies and the data obtained
in the present study, we suggest that this dual receptor binding
mode is also observed in Listeria for GW-domain-containing cell
wall binding proteins.
A model for the LTA glycosylation process involving two dis-
tinct glycosyltransferases and a sugar-linked undecaprenol phos-
phate intermediate (sugar-P-C55) has been proposed based on
biochemical studies performed in the 1980s (30–32) (Fig. 1A).
This model is based on the detection of sugar-P-C55 intermediates
in Streptococcus sanguinis and diverse Bacillus strains, including
Bacillus coagulans and Bacillus subtilis. These lipid-linked inter-
mediates are produced in the presence of the respective nucle-
otide-activated sugars (UDP-sugars), monophosphoryl undeca-
prenol and membrane protein fractions, indicating that the
enzyme catalyzing this step is a membrane-anchored glycosyl-
transferase (step 1 in Fig. 1A). In order to utilize the nucleotide-
activated sugar, the catalytic domain needs to be located in the
cytoplasm of the cell. As the LTA backbone is polymerized on the
outside the cell, the sugar can therefore only be linked to the poly-
mer on the outside of the cell. Thus, this requires that the sugar-
P-C55 intermediate is transported across the membrane, likely
with the aid of a dedicated transporter protein (step 2 in Fig. 1A).
It is then utilized on the outside of the cell by a second membrane-
bound glycosyltransferase with an extracellular catalytic domain
(step 3 in Fig. 1A), which transfers the sugar onto the final LTA
acceptor molecule. Experimental evidence supporting the notion
that two distinct glycosyltransferases are involved in this process
came from early work performed by Yokoyama et al. showing that
the formation of the Gal-P-prenol intermediate in B. coagulans
proceeds at an optimal pH of 8.4 and in the presence of MgCl2,
whereas the transfer of the galactose from this lipid intermediate
to the LTA polymer is most efficient at pH 4.5 in the presence of
CaCl2 (32).
We noted that the proposed LTA glycosylation process has
similarities to the mechanism by which 4-amino-4-deoxyl-L-ara-
binose (L-Ara4N) is linked to lipid A in E. coli and Salmonella
enterica serovar Typhimurium (54) and used this information in
the present study to identify GtlA (Lmo0933) as the glycosyltrans-
ferase involved in the LTA glycosylation process in L. monocyto-
genes. GtlA has homology to the E. coli glycosyltransferase ArnC,
which transfers 4-amino-4-deoxyl-4-formamido-L-arabinose (L-
Ara4FN) from UDP--L-Ara4FN onto the C55-P (34). Nearly 100
different families of glycosyltransferases have now been defined
(55); however, the structural fold of glycosyltransferases is limited
and the majority of enzymes assume either a GT-A or GT-B fold
(55). Recently glycosyltransferases with a third, so called “GT-C”
fold, have been defined; this fold is found in integral multi-trans-
membrane proteins with glycosyltransferase activity (55, 56). The
L. monocytogenes GtlA and E. coli ArnC proteins are both GT2
family enzymes with a GT-A fold glycosyltransferase domain at
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the N-terminal end and are retained within the membrane by two
C-terminal transmembrane helices. Based on the analogy to the
function of ArnC in the lipid A glycosylation process, we therefore
propose that GtlA is the glycosyltransferase required for the pro-
duction of the Gal-P-C55 lipid intermediate, which is subse-
quently used in the LTA glycosylation process (Fig. 1A, step 1).
However, further experiments and a biochemical characterization
of the L. monocytogenes GtlA enzyme are required to experimen-
tally confirm this notion.
While in this study we identified the first protein required for
the LTA glycosylation process, it is clear that other proteins are
required for this process, likely including a transporter protein to
move the sugar-P-C55 intermediate from the inside to the outside
of the membrane and a second glycosyltransferase with extracel-
lular activity. This second glycosyltransferase is likely to be a gly-
cosyltransferase with a GT-C fold, as several enzymes with this
fold have been shown to utilize lipid-linked sugars as the sub-
strates (35). However, none of the 15 glycosyltransferases anno-
tated in the Carbohydrate-Active enZYmes (CAZy) database for
L. monocytogenes strains EGD-e and 10403S falls into one of the
currently known families of glycosyltransferases with a GT-C fold.
The homology between known GT-C fold glycosyltransferases is
generally very low, and therefore these enzymes are difficult to
predict bioinformatically. But this makes it also very likely that
additional new families of glycosyltransferases will be uncovered
in the future in order to account for all of the cellular processes
requiring this class of enzymes.
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